Price
No data yet.
Social Signal Score
Revenue
$0.00-100.00%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- David J. Lennon
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 32
- Beta
- 0.78
- Country
- US
- Piotroski score
- 1 / 9 (Weak)
- Altman Z-score
- 11.96
Financials
Revenue
$0.00-100.0%Net Income
$-16.64MEBITDA
$-18.11MFree Cash Flow
$-14.53MEPS (diluted)
$-0.20Shares Outstanding (diluted)
82.89M+934.1%Operating Expenses
$18.11MCash & Debt
$189.98MReturn of Capital
$0.00Revenue by Segment (annual)
$7.14MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $7.14M | $-20.60M | $-0.33 |
| 2024 | $25.98M | $-63.69M | $-2.36 |
| 2023 | $24.35M | $-65.77M | $-2.44 |
| 2022 | $15.22M | $-60.51M | $-2.69 |
| 2021 | $1.12M | $-110.09M | $-12.41 |
| 2020 | $14.58M | $-3.48M | $-0.21 |
| 2019 | $749.0K | $-12.26M | $-1.65 |
Valuation
WHWKhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
120+20.00%Social Signal Score
Mentions (2)
- Newszacks.com·5h ago·Positive
What Makes Whitehawk Therapeutics, Inc. (WHWK) a Strong Momentum Stock: Buy Now? Does Whitehawk Therapeutics, Inc. (WHWK) have what it takes to be a top stock pick for momentum investors? Let's find out.
View source ↗ - Newszacks.com·2d ago·Neutral
Wall Street Analysts Predict a 47.64% Upside in Whitehawk Therapeutics, Inc. (WHWK): Here's What You Should Know The mean of analysts' price targets for Whitehawk Therapeutics, Inc. (WHWK) points to a 47.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
View source ↗
Earnings
Thu, Nov 5(in 2 months)
Consensus estimate $-0.27 per share
Typical surprise +32.4% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Aug 6$-0.20 vs $-0.30beat
- Thu, May 7$-0.32 vs $-0.36beat
- Thu, Mar 12$-0.34 vs $-0.55beat
- Thu, Nov 6$-0.26 vs $-0.51beat
- Thu, Aug 7$-0.76 vs $0.49miss
- Thu, May 8$1.83 vs $-0.46beat
Estimates and results for WHWK via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by WHWK officers and directors.
- Bought
- —
- Sold
- $2.6m
0 trades
14 trades
- Giacobello Scott M.sold
- Giacobello Scott M.sold
- Ball Bryansold
- Ball Bryansold
- Ball Bryansold
- Ball Bryansold
- Lennon David Jamessold
- Lennon David Jamessold
50 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.